** 在第 96 周,与安慰剂相比,阿帕西普有助于降低尿液中过量的蛋白质水平并稳定肾功能水平 - VERA
** VERA 表示,它将于 2025 年第二季度提交 (link) 阿卡西普特晚期研究结果。
** 截至上一交易日收盘,VERA 的股价已上涨了两倍多。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.